ALK-IN-29
ALK-IN-29 (compound 4c) has a certain inhibitory effect on tyrosine protein kinases ALK, CDK2/CyclinE1 and FAK, among which the strongest inhibitory effect on ALK kinase is 40.63% at a concentration of 10 μM. ALK-IN-29 can be used for anti-cancer research[1].
Product Specifications
UNSPSC
12352101
Target
Anaplastic lymphoma kinase (ALK) ; CDK; FAK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/alk-in-29.html
Smiles
O[C@H](C1)CC[C@@]2(C)C1=CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC(C4=N5)=C(C6=CC=C(F)C=C6)N7C5=CC=N7
Molecular Formula
C29H32FN3O
Molecular Weight
457.58
References & Citations
[1]Liu F, et al. Heterocycle-functional steroidal derivatives: Design, synthesis, bioevaluation and SARs of steroidal pyrazolo[1,5-a]pyrimidines as potential ALK inhibitors. Bioorg Chem. 2024 Sep 27;153:107847.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680525-100 1x 100 µL
CD63 (MX-49.129.5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472136-100 1x 100 µL
OCT-2 (POU2F2) (B-Cell Marker) (OCT2/2136), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741969-100 1x 100 µL
Thyroglobulin (Thyroidal Cell Marker) (r6E1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940205-100 1x 100 µL
Complement C4d (C4D205), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details